[Acute hepatitis and pneumonitis associated with nitrofurantoin]
Related Experiment Video
Updated: Jun 18, 2026

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
Published on: June 17, 2016
1Dept. of Medicine, Zevulun Clinic, Kiryat Motzkin.
Abstract:
Nitrofurantoin is widely used in the prophylaxis and treatment of urinary tract infections. Most untoward side-effects are mild and due to gastrointestinal intolerance. More severe side-effects consist of acute and chronic pulmonary reactions, liver damage, blood dyscrasias and peripheral neuropathy. Nitrofurantoin is a rare cause of hepatic injury, with a spectrum of toxic reactions ranging from acute, self-limited, hepatocellular or cholestatic injury to chronic active hepatitis. We present a case of acute hepatic injury and pneumonitis related to nitrofurantoin. When this drug is given periodic clinical and laboratory monitoring is important.
Insights
Nitrofurantoin, used for urinary tract infections, can cause severe side effects like liver damage and lung inflammation. Regular monitoring is crucial when prescribing this antibiotic to detect potential adverse reactions early.
Area of Science:
- Pharmacology
- Toxicology
- Infectious Diseases
Background:
- Nitrofurantoin is a common antibiotic for urinary tract infections (UTIs).
- While generally safe, it can cause adverse effects, ranging from mild gastrointestinal issues to severe organ damage.
- Severe side effects include pulmonary reactions, liver damage, blood disorders, and neuropathy.
Observation:
- This report details a case of acute hepatic injury and pneumonitis.
- The patient experienced adverse reactions attributed to nitrofurantoin use.
Findings:
- Nitrofurantoin is an infrequent but serious cause of liver injury.
- The drug's hepatic toxicity spectrum includes acute hepatocellular/cholestatic injury and chronic active hepatitis.
- Concurrent pneumonitis was observed in this case.
Implications:
- Healthcare providers should be aware of nitrofurantoin's potential for severe hepatic and pulmonary toxicity.
- Periodic clinical and laboratory monitoring is essential during nitrofurantoin therapy.
- Early detection and intervention can mitigate severe adverse events associated with nitrofurantoin.
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Hepatitis
Cryptococcal Meningitis
Pneumonia I: Introduction

